CME Cme Group Inc
Price (delayed)
$262.53
Market cap
$94.6B
P/E Ratio
27.09
Dividend/share
$10.5
EPS
$9.69
Enterprise value
$194.04B
CME Group Inc. is a global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals,
Highlights
CME's revenue is up by 10% year-on-year
The gross profit has increased by 10% YoY
CME's P/E is 16% above its last 4 quarters average of 23.3
The debt has grown by 9% year-on-year
Key stats
What are the main financial stats of CME
Market
Valuations
Earnings
Shares outstanding
360.36M
Market cap
$94.6B
Enterprise value
$194.04B
Price to earnings (P/E)
27.09
Price to book (P/B)
3.57
Price to sales (P/S)
15.39
EV/EBIT
41.66
EV/EBITDA
38.85
EV/Sales
31.65
Revenue
$6.13B
Gross profit
$6.13B
Operating income
$3.93B
Net income
$3.48B
EBIT
$4.66B
EBITDA
$4.99B
Free cash flow
$3.6B
Per share
Balance sheet
Liquidity
EPS
$9.69
EPS diluted
$9.67
Free cash flow per share
$10.01
Book value per share
$73.5
Revenue per share
$17.06
TBVPS
$297.63
Total assets
$137.45B
Total liabilities
$110.96B
Debt
$102.32B
Equity
$26.49B
Working capital
$719.6M
Debt to equity
3.86
Current ratio
1.01
Quick ratio
1
Net debt/EBITDA
19.91
Margins
Efficiency
Dividend
EBITDA margin
81.5%
Gross margin
100%
Net margin
56.8%
Operating margin
64.1%
Return on assets
2.6%
Return on equity
12.7%
Return on invested capital
4.6%
Return on capital employed
13.3%
Return on sales
76%
Dividend yield
4%
DPS
$10.5
Payout ratio
108.4%
CME stock price
How has the Cme Group stock price performed over time
Intraday
0.44%
1 week
1.6%
1 month
-0.4%
1 year
25.96%
YTD
13.05%
QTD
-1.04%
Financial performance
How have Cme Group's revenue and profit performed over time
Revenue
$6.13B
Gross profit
$6.13B
Operating income
$3.93B
Net income
$3.48B
Gross margin
100%
Net margin
56.8%
The operating income is up by 14% YoY and by 2.2% QoQ
CME's revenue is up by 10% year-on-year
The gross profit has increased by 10% YoY
The company's net income rose by 9% YoY
Growth
What is Cme Group's growth rate over time
Valuation
What is Cme Group stock price valuation
P/E
27.09
P/B
3.57
P/S
15.39
EV/EBIT
41.66
EV/EBITDA
38.85
EV/Sales
31.65
CME's P/E is 16% above its last 4 quarters average of 23.3
The EPS is up by 9% year-on-year
CME's price to book (P/B) is 37% higher than its 5-year quarterly average of 2.6 and 28% higher than its last 4 quarters average of 2.8
The equity has declined by 6% since the previous quarter
The P/S is 17% higher than the last 4 quarters average of 13.2 and 10% higher than the 5-year quarterly average of 14.0
CME's revenue is up by 10% year-on-year
Efficiency
How efficient is Cme Group business performance
The ROIC has grown by 21% YoY
Cme Group's return on assets has increased by 18% YoY
Cme Group's return on equity has increased by 9% YoY
Dividends
What is CME's dividend history
DPS
$10.5
Dividend yield
4%
Payout ratio
108.4%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Cme Group financials performed over time
Cme Group's total assets is 24% more than its total liabilities
Cme Group's total liabilities has increased by 8% YoY
Cme Group's total assets has increased by 6% YoY
The debt to equity has grown by 10% YoY and by 6% from the previous quarter
The debt has grown by 9% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.